chr2-47463021-C-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_000251.3(MSH2):c.1387-10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,460,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: not found (cov: 32) 
 Exomes 𝑓:  0.0000082   (  0   hom.  ) 
Consequence
 MSH2
NM_000251.3 intron
NM_000251.3 intron
Scores
 2
 Splicing: ADA:  0.002735  
 2
Clinical Significance
Conservation
 PhyloP100:  -0.214  
Publications
0 publications found 
Genes affected
 MSH2  (HGNC:7325):  (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012] 
MSH2 Gene-Disease associations (from GenCC):
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
 - Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
 - Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
 - mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
 - mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
 - ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
 - breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
 - hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72). 
BP6
Variant 2-47463021-C-G is Benign according to our data. Variant chr2-47463021-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 491767.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome  AF:  0.00000821  AC: 12AN: 1460936Hom.:  0  Cov.: 31 AF XY:  0.00000550  AC XY: 4AN XY: 726810 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
12
AN: 
1460936
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
4
AN XY: 
726810
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33450
American (AMR) 
 AF: 
AC: 
0
AN: 
44712
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26118
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39638
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86184
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53388
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5578
European-Non Finnish (NFE) 
 AF: 
AC: 
12
AN: 
1111516
Other (OTH) 
 AF: 
AC: 
0
AN: 
60352
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.404 
Heterozygous variant carriers
 0 
 1 
 3 
 4 
 6 
 7 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  Cov.: 32 
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Hereditary nonpolyposis colorectal neoplasms    Benign:1 
Jul 16, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary cancer-predisposing syndrome    Benign:1 
Sep 03, 2015
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Benign 
 dbscSNV1_RF 
 Benign 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.